The CDK4/6 inhibitor LY2835219 has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinoma

Deletion of CDKN2A (p16) or amplification of CCND1 (cyclin D1) occurs commonly in head and neck squamous cell carcinoma (HNSCC) and induces sustained cyclin-dependent kinase (CDK) 4/6 activation. Here, we report the antiproliferative activity of LY2835219, a selective CDK4/6 inhibitor through inhibi...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Ku, Bo Mi, Yi, Seong Yoon, Koh, Jiae, Bae, Yeon-Hee, Sun, Jong-Mu, Lee, Se-hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung-Ju
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2016
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4924753/
https://ncbi.nlm.nih.gov/pubmed/26909611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7543
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires